De novo peptide sequencing with InstaNovo: Accurate, database-free peptide identification for large scale proteomics experiments
Kevin EloffiD, Konstantinos KalogeropoulosiD, Amandla MabonaiD, Oliver MorelliD, Rachel CatzeliD, Esperanza Rivera‐de‐TorreiD, Jakob Berg JesperseniD, Wesley Williams, Sam P. B. van BeljouwiD, Marcin J. SkwarkiD, Andreas H. LaustseniD, Stan J. J. BrounsiD, Anne LjungarsiD, Erwin M. SchoofiD, Jeroen Van GoeyiD, Ulrich auf dem KelleriD, Karim BeguiriD, Nicolás López CarranzaiD, Timothy P. JenkinsiD
Abstract
Bottom-up mass spectrometry-based proteomics is challenged by the task of identifying the peptide that generates a tandem mass spectrum. Traditional methods that rely on known peptide sequence databases are limited and may not be applicable in certain contexts. De novo peptide sequencing, which assigns peptide sequences to the spectra without prior information, is valuable for various biological applications; yet, due to a lack of accuracy, it remains challenging to apply this approach in many situations. Here, we introduce InstaNovo, a transformer neural network with the ability to translate fragment ion peaks into the sequence of amino acids that make up the studied peptide(s). The model was trained on 28 million labelled spectra matched to 742k human peptides from the ProteomeTools project. We demonstrate that InstaNovo outperforms current state-of-the-art methods on benchmark datasets and showcase its utility in several applications. Building upon human intuition, we also introduce InstaNovo+, a multinomial diffusion model that further improves performance by iterative refinement of predicted sequences. Using these models, we could de novo sequence antibody-based therapeutics with unprecedented coverage, discover novel peptides, and detect unreported organisms in different datasets, thereby expanding the scope and detection rate of proteomics searches. Finally, we could experimentally validate tryptic and non-tryptic peptides with targeted proteomics, demonstrating the fidelity of our predictions. Our models unlock a plethora of opportunities across different scientific domains, such as direct protein sequencing, immunopeptidomics, and exploration of the dark proteome. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=130 SRC="FIGDIR/small/555055v3_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@20063org.highwire.dtl.DTLVardef@1679c01org.highwire.dtl.DTLVardef@1332940org.highwire.dtl.DTLVardef@1d9339f_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 44
- FWCI
- 11.41
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- De novo mass spectrometry peptide sequencing with a transformer model
Melih Yilmaz, William E. Fondrie, … William Stafford Noble·bioRxiv·Feb 7, 2022
- Sequence-to-sequence translation from mass spectra to peptides with a transformer model
Melih Yilmaz, William E. Fondrie, … William Stafford Noble·Nature CommunicationsPeer-reviewed·Jul 30, 2024
- Bridging the Gap between Database Search and De Novo Peptide Sequencing with SearchNovo
Jun Xia, Sizhe Liu, … Stan Ziqing Li·bioRxiv·Oct 19, 2024
- PepGo: a deep learning and tree search-based model for de novo peptide sequencing
Yuqi Chang, Siqi Liu, Karsten Kristiansen·bioRxiv·Feb 24, 2025
- Deep learning-driven fragment ion series classification enables highly precise and sensitive de novo peptide sequencing
Daniela Klaproth-Andrade, Johannes Hingerl, … Julien Gagneur·bioRxiv·Jan 5, 2023
- π-PrimeNovo: An Accurate and Efficient Non-Autoregressive Deep Learning Model for De Novo Peptide Sequencing
Xiang Zhang, Tianze Ling, … Siqi Sun·bioRxiv·May 17, 2024